Arginase 1 Deficiency News

Pegzilarginase Clinical Trial Update (January 2023)

Pegzilarginase Clinical Trial Update (January 2023) As Aeglea previously announced, we are in the process of concluding our ongoing pegzilarginase Phase 1 and Phase 3 clinical trials and transitioning those patients [...]

January 24th, 2023|

Redacted FDA Listening session

REDACTED - FDA Family-Led Listening Session Report On June 10, 2021, a group of patients and families affected by Arginase 1 Deficiency (ARG1-D) participated in a one-hour virtual listening session with [...]

March 23rd, 2022|

Caregivers’ Experiences Survey

We’re proud to partner with the Child Neurology Foundation to conduct a survey to understand caregivers’ experiences on their journey in child neurology. Results will be shared with advocates and health care [...]

March 4th, 2022|
Go to Top